The protective effects of GLP-1 RAs against cardiovascular events have been demonstrated in several studies, thus supporting their application in patients with heart failure with preserved ejection fraction and DM2 ( Taken together, GLP-1 is a major metabolic and regulatory hormone, with many potential therapeutic implications beyond glycemic control, encompassing cardiovascular protection, enhanced renal function, and the potential benefits in hepatic disease
An episode of low blood sugar (hypoglycemia)
The drug is widely adopted across 80+ countries, with nearly 65% of prescriptions focused on type 2 diabetes management and 35% on obesity-related applications
ADHD diagnosis and treatment guidelines: a historical review
By enhancing insulin sensitivity, attenuating systemic inflammation, and supporting mitochondrial function, GLP-1 RAs represent a promising strategy for decelerating the aging process and mitigating prevalent age-associated diseases such as T2D, CVDs, and NDs